Vanda Pharmaceuticals, Inc. (VNDA)


NasdaqGM - NasdaqGM Real Time Price. Currency in USD
15.33+1.16 (+8.19%)
At close: 4:00 PM EDT

15.33 0.00 (0.02%)
After hours: 5:02 PM EDT

People also watch:
XNPTOSIRSPPIACORPGNX
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Open14.50
Prev Close14.17
Bid14.78 x 300
Ask15.57 x 300
Day's Range14.18 - 15.38
52wk Range6.91 - 15.38
1y Target EstN/A
Market Cap663.55M
P/E Ratio (ttm)-15.95
Beta0.79
Volume2,615,722
Avg Vol (3m)628,126
Dividend & YieldN/A (N/A)
Earnings DateN/A
Trade prices are not sourced from all markets
  • TheStreet.com8 hours ago

    Vanda Pharma (VNDA) Stock Price Target Upped on Drug Patent Ruling

    JMP Securities increased Vanda Pharma's (VNDA) stock price target to $22 from $18 after a judge ruled that a generic drug maker's medication violated the company's patents.

  • American City Business Journals9 hours ago

    Vanda Pharmaceuticals fends off patent challenge from generic competitor

    Shares of D.C.-based Vanda Pharmaceuticals are trading higher for a second day in a row on news the company successfully defended its patents on its schizophrenia drug Fanapt. On Thursday, a U.S. District Court in Delaware ruled in favor of Vanda (VNDA) against another company seeking to market a generic version of Fanapt before Vanda's patents expire. Ohio-based generics maker Roxane Laboratories Inc. sought approval to manufacture and sell iloperidone, the active ingredient in Fanapt, to treat schizophrenia.

  • Capital Cube13 hours ago

    ETF’s with exposure to Vanda Pharmaceuticals, Inc. : August 26, 2016

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETF’s with exposure to Vanda Pharmaceuticals, Inc. Here are 5 ETF’s with the largest exposure to VNDA-US. Comparing the performance and risk of Vanda Pharmaceuticals, Inc. with the ETF’s that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)